Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma: An International, Multicenter Cohort Study.
Ammar Asrar JavedIngmar F RompenIris W J M van GoorThomas F StoopPaul AndelOmar MahmudAsad Saulat FatimiJoseph R HabibNabiha A MughalThijs SchoutenKelly LafaroRichard A BurkhartWilliam R BurnsHjalmar C van SantvoortMarcel den DulkFreek DaamsJ Sven D MieogMartijn W J StommelGijs A PatijnIgnace de HinghSebastiaan FestenMaarten W NijkampJoost M KlaaseDaan J LipsJan H WijsmanErwin van der HarstEric ManusamaCasper H J van EijckBas Groot KoerkampGeert KazemierOlivier R BuschI Quintus MolenaarLois A DaamenJin HeChristopher L WolfgangMarc G Besselinknull nullPublished in: Annals of surgery (2024)
This bi-national cohort demonstrates a true LTS rate of 9.0% in resected PDAC. Clinicians should remain aware that presence of poor prognostic factors does not preclude LTS.